Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
about
The role of infections in autoimmune diseaseImmunotherapy of Trypanosoma cruzi infection with DNA vaccines in miceModulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas diseasePentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell responseCytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagas' disease cardiomyopathy patients in response to T. cruzi ribosomal P proteinsProfile of central and effector memory T cells in the progression of chronic human chagas diseaseRegulatory T cells phenotype in different clinical forms of Chagas' diseaseSelective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathyInduction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions.Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.Myocardial gene expression of T-bet, GATA-3, Ror-γt, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response.Presence of antigen-experienced T cells with low grade of differentiation and proliferative potential in chronic Chagas disease myocarditis.Immunoregulatory networks in human Chagas disease.Chagas disease cardiomyopathy: immunopathology and genetics.Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.Different infective forms trigger distinct immune response in experimental Chagas diseaseType 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease.IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophilsMyocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10.Inhibition of autoimmune Chagas-like heart disease by bone marrow transplantationHumoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations.Human leucocyte antigen-G (HLA-G) and its murine functional homolog Qa2 in the Trypanosoma cruzi Infection.Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways.Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy.Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.Plasma cytokine expression is associated with cardiac morbidity in chagas disease.Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.Inflammation Enhances the Risks of Stroke and Death in Chronic Chagas Disease Patients.Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-statusMethodological approach to the ex vivo expansion and detection of T. cruzi-specific T cells from chronic Chagas disease patients.Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry.Histopathological Correlates of Global and Segmental Left Ventricular Systolic Dysfunction in Experimental Chronic Chagas Cardiomyopathy.Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.Chagas' disease: an update on immune mechanisms and therapeutic strategiesImmunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy.New diagnostic serum biomarkers for Chagas disease.
P2860
Q22242631-291EFF4D-9229-413A-AD4D-40FDB06A2EE9Q24602785-29B5E0C0-B106-4674-A1A3-CD33A59CC78AQ28083346-56FCD492-6DD8-49E4-B94D-12B1A53307C2Q28544692-403AE94B-F701-40FA-9055-E2E798CA22B5Q31164394-831BE56E-DF27-40FC-BF15-E2C8819D447FQ33501719-E8652022-F590-43AA-85C1-D465B5F32389Q33927456-6A7B30DC-0A35-4545-B0FB-5E4408C66380Q33955413-4FBD1190-3621-4BC6-979A-3A059D5518A3Q33997924-0D1E7529-FF31-49DD-8CBA-710C84B22FC7Q34032964-FD17854E-33A6-44E3-A288-4CF95A824C8FQ34053139-D34A70BE-3D1C-450C-A7BE-DE06D373B90DQ34075123-A27A8DC4-8186-4B1D-BE09-C78044831EA6Q34084644-1B4A5B97-7D53-431F-8ABF-A9E3AD6A69C5Q34125557-67B50E4E-E6EA-4419-92DE-2FFC23AB8FA8Q34179046-EF85F8B3-98AD-4BCE-AED5-5A3211EEEE37Q34193529-1D553849-6E5E-46F3-864D-1F012AD91B15Q34194841-78FD08CB-7A02-498C-8E4E-D3B51EC582F9Q34251395-FB00D72D-B706-4A7D-97D5-EFF1C47E38BDQ34266045-D02CEA74-2C3E-44CD-A16E-17350B6AFA65Q34476397-62F23180-2D57-41FE-A00B-832BE6AD3940Q34734088-391890A6-0568-483D-8A58-40DEAC3AE2BBQ35011455-905FEECA-7F20-40D1-A82E-BE2BB1725083Q35036373-A453078D-F533-4C39-87FB-19146C8B0513Q35061481-472C39DD-9E60-4E68-85A9-2FDB383A1A2BQ35065274-FA6F2E8B-B4DB-4961-B89D-4B19F654BBE3Q35075564-67C2C378-A74F-4DF9-AF1D-5055A089B3B0Q35085050-6B68A94D-4308-4279-B7A4-18034697C3C3Q35103414-8E5E86FE-37C3-4BF1-BE81-F84F53011EE8Q35112727-01E022CE-009A-4155-892E-5E8294E9AA58Q35915997-AD04B03E-9C05-4240-86E0-F8612C95E9E1Q35999538-DF7B5362-3A98-4D1A-8517-45192870BBF8Q36317381-B55372EF-4708-477E-AD79-2858FAE80542Q36383902-7F03788E-54CC-4C70-B5C7-6B38791B0321Q36385476-3F2CF288-989A-46F3-868E-5A26B8FC88B5Q36877827-31AE865F-0634-4CE0-910A-DB3FA92A72E0Q36904784-A0399C70-D0DB-41A1-A496-699C46FA3E53Q36933422-BFE7F97C-0359-4F0E-AD4E-0B7E698565D7Q37310959-4EDEF787-6D98-43E4-8FA2-7FAB62BC7FBFQ37597069-822AE6C2-8601-4C86-A02C-42C5C6DF20B5Q38088727-D51801DA-2407-4AD7-BCB4-F74E07A8D5E9
P2860
Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Chronic Chagas' disease cardio ...... o Trypanosoma cruzi infection.
@en
type
label
Chronic Chagas' disease cardio ...... o Trypanosoma cruzi infection.
@en
prefLabel
Chronic Chagas' disease cardio ...... o Trypanosoma cruzi infection.
@en
P2093
P356
P1476
Chronic Chagas' disease cardio ...... to Trypanosoma cruzi infection
@en
P2093
Albuquerque F
Teixeira HC
P304
P356
10.1006/JAUT.2001.0523
P577
2001-08-01T00:00:00Z